Japan supports new cancer treatment made from iPS cells

Japan supports new cancer treatment made from iPS cells
Cancer immunotherapy Source: Photo by Monstera Production on Pexels

Shinobi Therapeutics, a company in Japan, is working on a new treatment for cancer. The treatment is called NJA-001. It is now on a list of projects chosen by AMED, a Japanese government group that gives money for medical research.

Japan supports new cancer treatment made from iPS cells
Cancer immunotherapy Source: Photo by Monstera Production on Pexels

NJA-001 is made from iPS cells. Scientists use these cells to make T cells, which can find and kill sick cells in the body. The T cells in NJA-001 are designed to look for GPC3. Many cancer cells make a lot of GPC3. It is common in liver cancer and in some other solid cancers.

Most cell treatments today are made from the patient's own blood. NJA-001 is different. It is made in advance from iPS cells that do not come from the patient, so it is ready to use, like a product off the shelf. The cells are also made in a special way so the patient's body does not reject them. Because of this, doctors can give the treatment many times.

The company plans to test NJA-001 in people at three hospitals in Japan. They are a center for new treatments at Kyoto University Hospital, the National Cancer Center Hospital East, and the Cancer Institute Hospital in Tokyo. For the phase Ib trial, the company also plans to add hospitals in the United States.

Glossary

  • 216 words
  • 16 sentences
  • 2 mins to read